FDA approves Amgen biosimilar of AbbVie’s Humira
The Food and Drug Administration approved Amgen’s Humira biosimilar Sept. 23. Amjevita, formerly known as ABP 501 and made by Thousand Oaks-biotech giant Amgen, replicates the effects of Humira, which is approved to treat nine conditions including rheumatoid arthritis, skin disorders and colon inflammation. Humira, made by Chicago-based competitor AbbVie, typically costs $20,000 per year Read More →
SOAR creates disparity in land values
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Rams spark home price surge in Ventura County
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Rams executive says team on mission to help Conejo Valley
Los Angeles Rams Chief Operating Officer Kevin Demoff spoke about a mission to help the Conejo Valley community, area businesses and California Lutheran University on Sept. 16. Demoff talked about the vision the team has for expanding football in the region, Olympic and Super Bowl bids for the Rams’ new Inglewood Stadium and the challenges Read More →
California Economic Forecast predicts no recession in 2016 or 2017
Economic indicators do not point to a recession this year or next, according to research from the California Economic Forecast. Nationwide, consumer confidence is near a seven-year high and corporate profits are trending up, which slumped prior to the Great Recession. And even though more people are buying cars and homes, household debt levels are Read More →